- [PRESSWIRE] TORONTO, Ontario and CAMBRIDGE – Mass. — January 27, 2022 — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today that it has appointed Dr. Cheryl Wellington to its scientific advisory board (SAB).
- • Rapid molecular PCR-like accurate saliva-based test delivers 95% sensitivity and 98% specificity in symptomatic and asymptomatic individuals with SARS-CoV-2 including variants • Designed for point-of-care (POC) diagnosis, ease of use, rapid and cost-effective mass-screening • A mobile-enabled, multiplex platform and connected solution enables efficient real-time reporting of results, track & trace, and surveillance
- [PRESSWIRE] TORONTO, Ontario and CAMBRIDGE, Mass. — January 18, 2022 — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today that it has initiated a program to develop monoclonal antibodies to treat schizophrenia and other chronic mental illnesses. Schizophrenia is a clinical term for a severely disabling neuropsychiatric disease that disrupts employment, families and communities, and likely has heterogenous biological origins.
- [PRESSWIRE] TORONTO, Ontario and CAMBRIDGE, Mass. — January 7, 2022 — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today its participation in the Biotech Showcase 2022 virtual panel discussion to be held on Jan. 11, 2022 from 8 AM to 9 AM PST.
- [PRESSWIRE] London – 13 December 2021 — Theramex is excited to announce the appointment of Camilla Harder Hartvig as Chief Commercial Officer as of 1st January 2022 particularly during a pivotal moment in the company’s development in Consumer Healthcare.
- [PRESSWIRE] Austria – 10.12.21 — CEBINA GmbH, Central European Biotech Incubator and Accelerator, today informs about the potential of the antihistamine drug azelastine hydrochloride to be an effective anti-viral approach against major respiratory viruses, such as SARS-CoV-2 and its variants, influenza and Respiratory Syncytial Virus (RSV).
- [PRESSWIRE] Japan – 21 October, 2021 — Post COVID-19 syndrome, a developing world-wide problem may be alleviated by Japan originated medical device “suisonia”.
- [PRESSWIRE] US – 29 September, 2021 — Riccobene Associates Family Dentistry is pleased to announce the election of Mr. Line Dempsey as President-Elect for the Council on Licensure, Enforcement, and Regulation (CLEAR).
- [PRESSWIRE] US – 29 September, 2021 — Riccobene Associates Family Dentistry (RAFD) has hired Lorri Detrick to fill its Chief Operations Officer role.
- [PRESSWIRE] Italy – 06 June, 2021 — Climate change represents one of the greatest global health threats of our time. In choosing Healthy Environment, Healthy Kidneys as the theme for the 2021 fully virtual Congress, the ERA-EDTA highlights the central role of nephrologists and other health professionals in advocacy for global efforts to reduce emissions and protect against climate change.
- Dangerous lung congestion or overhydration can be detected relatively easily in dialysis patients by means of ultrasound examinations and the application of this technique is useful to safely guide lung decongestion.
- The progressive loss of renal function in focal segmental glomerulosclerosis (FSGS) was reduced by half in the DAPA-CKD study…
- There is now evidence of how SGLT2 inhibitors slow the progression of chronic kidney disease, regardless of diabetes status…
- Iptacopan, an oral, alternative complement pathway inhibitor of Factor B, could provide the first therapy targeted at one of the key drivers of IgAN…
- The selective C5a receptor inhibitor avacopan could be used in future to treat immune-mediated inflammatory disorders in C3G renal disease.
- [PRESSWIRE] Italy – 05 June, 2021 — One in ten adults in Europe has reduced kidney function. It is a cruel fact that many of those affected do not notice their progressive renal insufficiency.
- [PRESSWIRE] Italy – 05 June, 2021 — That viruses and bacteria can trigger autoimmune processes is well known. In autoimmune disease, the immune system attacks the body’s own cells, which can become life-threatening, for example in lupus nephritis.
- [PRESSWIRE] Italy – 05 June, 2021 — It was realized early on in the pandemic that kidney values can predict a severe COVID-19 course [1]. The German S3 guidelines for inpatient treatment [2] therefore advise that urine and kidney values be measured on admission to the accident and emergency unit.
- [PRESSWIRE] Italy – 05 June, 2021 — Renal tropism or virus detection can be associated with severe course, greater incidence of acute kidney injury (AKI) and earlier death – yet the immediate role of the virus in the kidney has not been clarified.
- [PRESSWIRE] Parma, Italy – 05 May, 2021 — One in ten adults in Europe suffer from reduced kidney function and yet many will be unaware of this. What is fatal is that the loss of kidney function cannot be reversed. It is therefore essential that the general public are made aware of the importance of the kidneys and how to protect them.
- [PRESSWIRE] Austria – 04 May, 2021 — CEBINA GmbH, an Austrian biotech company, today announces that azelastine, previously identified as a potential anti-COVID-19 drug, is equally potent against newly emerging dominant variants of SARS-CoV-2 compared to the original virus. Azelastine is available as an anti-allergy nasal spray and is currently being tested in a Phase 2 efficacy trial for the treatment of early-stage COVID-19 disease.
- [PRESSWIRE] Brussels – 22.03.21 — One year after the start of the corona pandemic, the city network Eurocities invites everyone to a European minute of silence. The joint commemoration takes place next Wednesday, 24 March, at 12:00 noon CET.
- [PRESSWIRE] GERMANY – 01 March, 2021 — Advances in healthcare IT will be unveiled by Konica Minolta at the European Congress of Radiology Virtual Exhibition from March 3-10. Taking centre stage will be the launch of AeroDR X90, a high-end auto positioning X-ray system, and Sonimage HS2, a premium portable ultrasound device, as well as Exa Enterprise Imaging offering full diagnostic toolsets and viewing capabilities.
- [PRESSWIRE] NOBLESVILLE, Indiana – February 22, 2021 -— B Medical Systems, a Luxembourg-based manufacturer of medical device registered refrigeration and cold transport solutions, announced today that they have been awarded a group purchasing agreement with Premier. Effective April 1, 2021, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for B Medical Systems’ products and solutions in the General Laboratory Products, Equipment, and Service Category.
- [PRESSWIRE] London, UK – 18 February, 2021 — Obesity has been proven to increase the risk of death from Covid – now a leading specialist is offering a solution.
- [PRESSWIRE] Vienna, Austria – 17 February, 2021 — In the fight against the SARS-CoV-2 virus, a large number of pharmaceutical companies are looking for new approaches to combat the pandemic. In addition to vaccines, intensive research and development efforts around the world are focusing on identifying new anti-COVID therapeutics that includes re-evaluation of existing product portfolios with a view to re-purpose drugs that have antiviral properties.
- [PRESSWIRE] Madrid, Spain – 25 January, 2021 — An innovative new technology from Necenti Labs offers 96% accuracy for COVID-19 detection before infection with deep data to give companies and individuals the power of knowledge to battle lockdown.
- [PRESSWIRE] SANTA ANA, January 26, 2021 — Airionex, the leading global provider of bi-polar ionization air and surface purification technology, announced today that it has hired Françoise Parker as Senior Vice President of Sales and Marketing. Françoise will report to CEO Jukka Matikka, and will be responsible for sales team leadership, accelerating Airionex revenue throughout North America, the development and management of key channels, and overseeing the company’s marketing strategy.
- [PRESSWIRE] Australia – 08 January, 2020 — A study carried out at the end of October by the University of Bern, Switzerland, certified that the masks with nano copper particles patented by the Chilean science-fashion company, The Copper Company, eliminate 85% of the SARS-CoV-2 in 5 minutes and, in 2 hours, up to 95%.
- [PRESWIRE] Russia – 29 December, 2020 — Lately, experts around the globe, and especially in Europe, have been actively raising regarding the right of the public to have access to medical treatment and diagnosis information regarding politicians and political cases.